fda covid vaccine - Search News

Order byBest matchMost fresh

FDA Will Approve COVID-19 Vaccine

Top News

Overview

Impacts

FDA may limit future Covid-19 shots to older people and those at risk of serious infection

The change means that Covid-19 shots will likely be available in the fall for adults ages 65 and older and those with underlying conditions that may put them at higher risk of a Covid-19 infection, b...

· 2d · on MSN

· 13h

FDA won’t approve COVID shot for healthy, non-elderly population

· 10h

FDA Warns of Heart Risk With Pfizer, Moderna COVID Vaccines

FDA tightens requirements for COVID vaccine, adding trials for healthy adults

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day.

· 1d

F.D.A. Poised to Restrict Access to Covid Vaccines

· 6h

FDA panel recommends keeping COVID shots targeted to same strain as last year

US FDA Advisers to Weigh Composition of COVID Vaccines for 2025-2026

Public health experts say that there is no certainty on which strains are going to be dominant.

· 10h

· 1d

FDA plans to limit COVID vaccine to only high-risk people. Who would still be eligible?

· 11h

FDA panel debates COVID vaccine recipe as questions swirl about fall shots

2hon MSN

With vaccine approval process set to change, FDA advisers leave wiggle room in annual Covid-19 shot recommendations

A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make a broad recommendation about which lineage of the coronavirus should be included in this year’s Covid-19 vaccines,

6hon MSN

Changes are happening around COVID-19 vaccines: Here's what to know

The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels about heart inflammation.

The New Rational FDA COVID Vaccine Policy is Long Overdue, Says NanoViricides’ Dr. Diwan

SHELTON, CT / ACCESS Newswire / May 22, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE Amer.:NNVC ) (the “Company”), comments on the new COVID Vaccine policy adopted by the US FDA. The new FDA COVID Vaccine Booster Shots policy [1] is based on the findings that the groups that benefit from repeat

Explore more

Food and Drug Administration